These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17474988)

  • 21. The diagnostic efficacy of nectin 4 expression in ovarian cancer patients.
    Nabih ES; Abdel Motaleb FI; Salama FA
    Biomarkers; 2014 Sep; 19(6):498-504. PubMed ID: 25019423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
    Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
    BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry.
    Nam SE; Lim W; Jeong J; Lee S; Choi J; Park H; Jung YS; Jung SP; Bae SY
    Breast Cancer Res Treat; 2019 Oct; 177(3):669-678. PubMed ID: 31312932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.
    Arslan N; Serdar M; Deveci S; Ozturk B; Narin Y; Ilgan S; Ozturk E; Ozguven MA
    Ann Nucl Med; 2000 Oct; 14(5):395-9. PubMed ID: 11108173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
    Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
    Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nectin-4 and p63 immunohistochemical expression in canine prostate tumourigenesis.
    Della Salda L; Massimini M; Romanucci M; Palmieri C; Perillo A; Grieco V; Malatesta D; Spinillo MA; Passantino G; Dondi F; Benazzi C
    Vet Comp Oncol; 2019 Sep; 17(3):298-307. PubMed ID: 30767361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum CA15-3 levels correlate with positive estrogen receptor and initial favorable outcome in patients who died from recurrent breast cancer.
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H
    Breast Cancer; 2003; 10(3):220-7. PubMed ID: 12955034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer.
    Deprés-Brummer P; Itzhaki M; Bakker PJ; Hoek FJ; Veenhof KH; de Wit R
    J Cancer Res Clin Oncol; 1995; 121(7):419-22. PubMed ID: 7635872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMP13 is potentially a new tumor marker for breast cancer diagnosis.
    Chang HJ; Yang MJ; Yang YH; Hou MF; Hsueh EJ; Lin SR
    Oncol Rep; 2009 Nov; 22(5):1119-27. PubMed ID: 19787229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.
    Boylan KL; Buchanan PC; Manion RD; Shukla DM; Braumberger K; Bruggemeyer C; Skubitz AP
    Oncotarget; 2017 Feb; 8(6):9717-9738. PubMed ID: 28038455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
    Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
    Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis.
    Izumi H; Hirabayashi K; Nakamura N; Nakagohri T
    Surg Today; 2015 Apr; 45(4):487-94. PubMed ID: 25690753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
    Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
    Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of laminin-5 in breast carcinoma cells.
    Martin KJ; Kwan CP; Nagasaki K; Zhang X; O'Hare MJ; Kaelin CM; Burgeson RE; Pardee AB; Sager R
    Mol Med; 1998 Sep; 4(9):602-13. PubMed ID: 9848077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors].
    Ruibal A; Garrido Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(3):180-3. PubMed ID: 16762272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.